Folic Acid-Conjugated Solid Lipid Nanoparticles for Ratiometric Combination Delivery of Docetaxel and Erlotinib in Triple-Negative Breast Cancer Therapy
Aiswarya Chaudhuri, Dulla Naveen Kumar, Rohan Chand Sahu, Dinesh Kumar, Ashish Kumar Agrawal. Folic Acid-Conjugated Solid Lipid Nanoparticles for Ratiometric Combination Delivery of Docetaxel and Erlotinib in Triple-Negative Breast Cancer Therapy. // AAPS PharmSciTech. – 2026. – DOI: 10.1208/s12249-026-03561-w. – URL: https://doi.org/10.1208/s12249-026-03561-w
Aiswarya Chaudhuri, Dulla Naveen Kumar, Rohan Chand Sahu, Dinesh Kumar, & Ashish Kumar Agrawal (2026). Folic Acid-Conjugated Solid Lipid Nanoparticles for Ratiometric Combination Delivery of Docetaxel and Erlotinib in Triple-Negative Breast Cancer Therapy. AAPS PharmSciTech. https://doi.org/10.1208/s12249-026-03561-w
Aiswarya Chaudhuri, et al. “Folic Acid-Conjugated Solid Lipid Nanoparticles for Ratiometric Combination Delivery of Docetaxel and Erlotinib in Triple-Negative Breast Cancer Therapy.” AAPS PharmSciTech, 2026. doi:10.1208/s12249-026-03561-w.
@article{Chaudhuri2026,
title = {Folic Acid-Conjugated Solid Lipid Nanoparticles for Ratiometric Combination Delivery of Docetaxel and Erlotinib in Triple-Negative Breast Cancer Therapy},
author = {Chaudhuri, Aiswarya and Kumar, Dulla Naveen and Sahu, Rohan Chand and Kumar, Dinesh and Agrawal, Ashish Kumar},
journal = {AAPS PharmSciTech},
year = {2026},
doi = {10.1208/s12249-026-03561-w},
url = {https://doi.org/10.1208/s12249-026-03561-w}
}